Key Record Dates Identifier: NCT03544281
Brief Title: To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 6)

First Submitted : April 30, 2018
First Submitted that Met QC Criteria : May 23, 2018
First Posted : June 1, 2018

Last Update Submitted that Met QC Criteria : May 17, 2021
Last Update Posted : May 19, 2021